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MicrovesicleFormins are a conserved family of proteins that play key roles in cytoskeletal remodeling. They nucleate and
processively elongate non-branched actin ﬁlaments and also modulate microtubule dynamics. Despite their
signiﬁcant contributions to cell biology and development, few studies have directly implicated formins in
disease pathogenesis. This review highlights the roles of formins in cell division, migration, immunity, and
microvesicle formation in the context of human disease. In addition, we discuss the importance of controlling
formin activity and protein expression to maintain cell homeostasis.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Formin family proteins—so-called because of conserved formin-
homology-1 and -2 (FH1 and FH2) domains—have emerged as key
regulators of actin and microtubule cytoskeletal dynamics during cell
division and migration. The FH1 and FH2 domains were identiﬁed by
Castrillon and Wasserman in the initial characterization of the Dia-
phanous gene in Drosophila [1], and both domains participate in the
control of cytoskeletal remodeling. The proline-rich FH1 domains
have been shown to bind to numerous WW- and SH3-domain
containing proteins in addition to proﬁlin-actin, which contributes to
the ability of formins to produce non-branched actin ﬁlaments. FH2
domains dimerize, then nucleate and processively elongate linear
actin ﬁlaments by associating with their growing barbed (+) ends.Signal Integration, Van Andel
s, MI 49503, USA.
ll rights reserved.These FH2 dimers create an environment that favors actin monomer
addition to generate actin ﬁlaments.
While formins are important for actin remodeling events, formins
can also modulate microtubule dynamics [2] in at least two different
ways. Diaphanous-related formins (DRFs), the family of formins most
closely related to the canonical formin Diaphanous, bind directly to
microtubules to promote their stabilization [3]. In addition, mamma-
lian DRF (mDia) proteins have been shown to associate with
microtubule-end binding proteins EB1 and APC [4]. APC is the product
of the adenomatous polyposis coli (APC) familial colon cancer tumor
suppressor gene, and its role in disease progression may be mediated
in part by mDia family proteins. Emerging evidence suggests that the
formin mDia1 possesses tumor suppressor activity [5], again pointing
to a role for formins in cancer formation.
Defects in cytoskeletal remodeling proteins have previously been
implicated in malignancy [6] and the aforementioned association
between mDia proteins and tumor suppression may point to speciﬁc
roles for formins in cancer and other diseases. However, despite the
signiﬁcant roles formins play in cell biology and development [7],
there have been relatively few studies that directly link formins with
disease pathogenesis. This review highlights the existing body of
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function contributes to disease.2. Cytoskeletal remodeling and the cell cycle
Inappropriate cell cycle regulation and cell division are often
responsible for the cellular changes that lead to human disease.
Changes in cell morphology, chromosome segregation, and vesicular
trafﬁcking are all fundamental events that occur during cell division.
Each of these events are governed by cytoskeletal remodeling, and it is
not surprising then that formins are centrally involved in many
aspects of cell division. In fact, one of the best-characterized roles for
formins is a necessary function during cytokinesis [1,8,9].
Cytokinesis occurs in the last stage of cell division to physically
separate the mother cell into two daughter cells. This process requires
the formation of an actin-rich contractile ring that constricts to induce
plasma membrane invagination. Completion of cytokinesis is marked
by abscission of the daughter cells. Importantly, disruption of formin
function by mutation or genetic deletion often results in cytokinesis
failure (Fig. 1). This initial discovery was made in Drosophila after loss
of the Dia allele led to aneuploidy in germ cells [1]. Subsequent work
in other species has shown that numerous formins play a critical role
in cytokinesis [7].
Failure to divide the daughter cells after karyokinesis results in a
tetraploid cell. Surviving tetraploid cells are prone to genomic
instability, widely thought to contribute to cancer initiation and
progression [10]. Therefore, inappropriate control of formin function
or expression in humans may be a critical event in cancer deve-
lopment. However, there is no evidence that directly links cytokinesis
failure with cancer as a consequence of defective formin function,
despite the conserved role for formins in cytokinesis.Fig. 1. Formins in cytokinesis. Formins are required for cytokinesis through the assembly o
vesicle trafﬁcking may also be a required formin function during cytokinesis. Loss of formin
and lead to binucleate cells, which can result in chromosome instability.As mentioned previously, formins can also modulate microtubule
dynamics. How formins stabilize microtubules is reviewed in detail by
Bartolini and Gundersen [2]. In the context of cell division,
microtubule stabilization is required to facilitate chromosome
segregation and midbody formation [11]. mDia1 has been shown to
localize to spindle microtubules in dividing HeLa cells [12]. However,
the contribution of mDia function toward spindle assembly and
dynamics remains unclear. mDia1 andmDia2 have also been shown to
decorate the midbodies of dividing cells [13]. The midbody, a dense
region of stablemicrotubules at the site of abscission, helps coordinate
vesicle trafﬁcking to promote the membrane remodeling required for
cell separation. It is likely that formin-mediated microtubule
stabilization contributes to the trafﬁcking events during cell division,
especially considering that formins control vesicle trafﬁcking in other
cellular contexts as well [14–16].
In summary, formin activity is critical for proper cell division and
thus for the maintenance of genomic integrity during cell division.
Future studies are likely to link formins with cancer initiation or other
diseases directly, given the fundamental role of formins during
cytokinesis.
3. Formins in cancer cell migration and invasion
Mammalian cells display remarkable capacities for migration,
invasion, and morphological plasticity, and these attributes make
possible numerous biological processes of central interest in the
understanding of development, homeostasis and disease. Cells of the
immune system, in particular, are capable of precisely targeted
homing and invasion of tissues; cells in metastatic cancer are similarly
capable of migration and invasion. These processes are known to
depend on dynamic modulation of the cytoskeleton. A thorough
understanding of these processes is essential for progress in diagnosisf the contractile actin ring. The ability of formins to stabilize microtubules and control
activity or deregulation of formin activity has been shown to interfere with cytokinesis
Fig. 2. Formins and cell migration. Formins control adherent cancer cell migration and invasion by assembling actin-rich protrusive structures and stabilizing microtubules. Formins
perform similar functions in immune cells, and studies from mDia1 knockout mice show that they also play a role in immune cell proliferation. In prostate cancer cells, the formin
mDia2 was shown to control microvesicle formation, which could lead to oncogenic signal transmission to nearby cells.
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migration or invasion is centrally involved.
The reorganization of the actin cytoskeleton drives morphological
changes during directed cell migration and invasion in normal and
malignant cells. Much attention has focused upon the Rho subfamily
of small GTPases, and their enhanced expression and/or activation in
human cancers, proteins fundamental to actin remodeling; yet,
historically, little is known about the role of key downstream effector
proteins propagating Rho signaling in migrating/invading cancer
cells. In the past several years, signiﬁcant progress in the understand-
ing of cytoskeletal dynamics has led to the construction of detailed
and useful models of these pathways. In particular, an emerging
understanding of the functions and roles of formins has generated a
model of formin-based actin polymerization and microtubule stabi-
lization, usually in the context of Rho GTPase signaling. Collectively,
this emerging evidence (brieﬂy discussed below) suggests a role for
the formin family of proteins in modulating both actin- and
microtubule-based cytoskeletal networks to promote cancer cell
adhesion, migration and ultimately invasion (Fig. 2).
3.1. mDia1
mDia1 has been implicated in a variety of distinct processes
driving normal and cancer cell polarity and migration. mDia1 has
been demonstrated to bind, stabilize and polarize microtubules from
the cell center to the periphery in migrating cells [4,17–21]. mDia1-
dependent microtubule polarization and reorientation of both the
microtubule organizing center (MTOC) and the Golgi toward the
direction of cellularmigration is fundamental in drivingmigration and
is dependent upon members of the Rho family of GTPases, including
Cdc42 and RhoA (reviewed in [22,23]).
Acting as a Rho GTPase effector protein, mDia1 also has a critical
role in promoting the formation of actin-rich protrusions by building
F-actin ﬁlaments and directing signaling networks at the leading edge
of migrating cells. For instance, in the context of N-WASp-depleted
adenocarcinoma cells, mDia1 drives actin-enriched cellular protru-
sions and stress ﬁber formation in a RhoA-dependent manner [24].
Furthermore, through interaction with the cytoskeletal scaffolding
protein IQGAP, mDia1 was localized to the leading edge of migrating
ﬁbroblasts [25]. mDia1 has been shown to control the formation of
stable actin ﬁlaments and promote the formation and turnover of
focal adhesions [13,17,19,20]. Recently, it was shown that mDia1
knockdown inhibited formation of focal contacts, decreased lamelli-
podial thickness and impeded leading edge dynamics in migrating
cells [20], while another study showed that mDia1 depletion inhibited
Src accumulation into focal adhesions in migrating glioma cells,
impairing focal adhesion function and stability, as well as cellular
migration [19]. Furthermore, through direct interaction with the cell-surface receptor for advanced glycation end products (RAGE), mDia1
was shown to promote RAGE-ligand-stimulated cellular migration in
a manner dependent upon activated Rac and Cdc42 [26]. Thus, the
role of mDia1 in cellular migration appears to be complex, involving
multiple platforms (actin and microtubule cytoskeletons) and
affecting cell polarity and the assembly of cytoskeletal structures
supporting leading edge dynamics.3.2. mDia2
Like mDia1, the related formin mDia2 has also very recently been
implicated in cellular migration in both normal and cancer cells. For
instance, the zebraﬁsh homologue of mDia2, zDia2 (sharing approx-
imately 50% and 80% sequence homology to human and mouse
mDia2, respectively), was shown to be involved in cell motility
observed during gastrulation [27]. A morpholino-based zDia2 knock-
down strategy uncovered a role for zDia2 in the formation of actin-
rich protrusions observed during gastrulation and revealed that
proﬁlin I was coordinately involved downstream of zDia2 signaling to
control cellular migration during gastrulation. Interestingly, the
authors showed that zDia2 expression directed the formation of
membrane blebs in the front row of marginal deep cells in zebraﬁsh at
the germ-ring stage of gastrulation. As membrane blebbing is an
initial indicator of cellular motility accompanying the transformation
of non-motile blastomeres into motile blastula cells, these results
suggest a role for mDia2 homologues in cellular migration in vivo.
Moreover, these results conﬁrm in vitro evidence that mDia formins
control cortical actin contractility and that their disruption promotes
the plasma membrane blebbing that is a hallmark of the amoeboid
type of cellular motility demonstrated in cervical and prostate cancer
cells [28,29]. In a recent study by Di Vizio et al. (discussed further
below), mDia2 depletion in DU145 and LNCaP prostate cancer cells
enhanced blebbing upon EGF addition and a concomitant increase
in motility and invasion was observed. Furthermore, invasion of
MDA-MB-231 breast cancer cells in Matrigel was dependent upon
mDia formins, and mDia2 was localized with Src to invadopodia;
mDia2-depleted MDA-MB-231 cells had few invadopodia, pointing
toward mDia2 as an important component in breast cancer cell
invasion [30].
Finally, in addition to affecting the actin cytoskeleton during
cellular migration and invasion, it is very likely that, like mDia1,
mDia2 also inﬂuences the microtubule cytoskeleton in migrating
cells. Indeed, it was recently shown that mDia2 stabilized micro-
tubules independent of its ability to modulate actin ﬁlament
assembly [3]; this study illustrated the importance of understanding
whether the microtubule stabilizing activity of mDia2 formin is also
fundamental to cellular processes in which this formin previously
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stability [31].
3.3. Other formin family members (FHOD/FHOS, Formin 1, dDia2, FRL)
In addition to the mDia family, other formins have been shown
to play roles in generating actin-rich protrusions that promote
cellular migration in a variety of cells and organisms. The Formin-
homology-2-domain-containing protein (FHOD1) was demonstrated
to enhance cellular migration upon overexpression in human
melanoma cells, as well as in NIH 3T3 cells, without signiﬁcantly
affecting integrin expression/activation or cellular adhesion as a
whole [32].
Other formins with only moderate homology to mDia formins
were also shown to function in cellular migration, including Formin 1
isoform IV (Fmn1-IV), D. discoideum Dia2 (dDia2), and formin-related
gene in leukocytes (FRL). For instance, Fmn1-IV is a formin protein
with some sequence similarity to dishevelled-associated activator of
morphogenesis-1 (DAAM1); Dettenhoffer et al. generated Fmn1-IV
knock-in mice and demonstrated in primary kidney epithelial cells a
role for Fmn1-IV in cell spreading and focal adhesion formation [33].
Conversely, mouse embryonic ﬁbroblasts (MEFs) derived from Fmn1-
IV knockout mice, which show weakly penetrent kidney aplasia [34],
had altered protrusive behavior at the leading edge of the cells and
had defective cell spreading and focal adhesion formation [33].
Overexpression in D. discoideum of dDia2, which has some sequence
similarity to mammalian DAAM1 (∼42%) and to a lesser extent hDia2,
led to the formation of more persistent, larger adhesive contacts
between ﬁlopodia and substrate, suggesting a role for dDia2 in
controlling ﬁlopodia dynamics and the formation of adhesive struc-
tures important for cell motility [35]. Finally, Formin-related gene in
leukocytes (FRL) was shown to inﬂuence cell adhesion, cell
spreading, lamellipodia formation and chemotactic migration [36].
In those studies, overexpression in macrophages of the FH3 domain
(referred to as the DID domain in recent studies [37]), containing
the Rac-binding domain, was sufﬁcient to inhibit cell spreading as
well as lamellipodia formation upon stimulation with the chemokine
SDF1α (CXCL12); expression of the FH3 domain was also sufﬁcient to
ablate cell adhesion to ﬁbronectin and inhibit chemotactic migration
toward SDF1α, indicating a role for this understudied formin in cell
motility.
4. Formins in microvesicles
In addition to soluble proteins and other hormones, cells shed
membrane vesicles into the extracellular environment. These extrud-
ed vesicles have been shown to contain various signaling proteins and
microRNAs, and their contents can be transferred to neighboring cells,
resulting in changes in proliferative and/or migratory capacity
[29,38]. These structures range in size from ∼50 nm to several
microns in diameter and have been characterized in various guises as
exosomes, ectosomes, argosomes, microparticles, and oncosomes
[39]. We will refer to them as microvesicles here.
Microvesicles are believed to arise by budding directly from the
plasma membrane, but they appear to originate from multiple
sources, which include organelles from the endocytotic and endo-
some processing/trafﬁcking apparatus. Several lines of evidence
suggest that formins are involved in both the formation and the
emission of microvesicles (Fig. 2). Early work on mDia1 and mDia2
found both proteins on endosomal structures along with Src non-
receptor tyrosine kinases [13]. Subsequent studies demonstrated that
all mammalian Diaphanous-related formins (mDia1-3) have roles in
endosome trafﬁcking [15,40]. Moreover, formin inhibition leads to an
induction of non-apoptotic membrane blebbing in numerous cell
types [28].Whether any of the formin-associated vesicles gives rise to
microvesicles has yet to be demonstrated. However, recent work by
Di Vizio et al. [29] has provided solid evidence that formins directly
participate in microvesicle production and thereby function to
encourage tumor growth and metastasis. Their studies focused on
EGF-induced blebbing of prostate tumor cells, which results in the
shedding of microvesicles termed “oncosomes.” These microvesicles
contain various signaling proteins and alter signaling in other cells.
Notably, Akt phosphorylation is induced in cells exposed to micro-
vesicles shed by prostate cancer cells. Similar results obtained in
glioblastoma cells [38] suggest that such phenomena are occasionally
associated with metastatic cancer cells and/or amoeboid cell
migration. Di Vizio et al. also tested whether mDia2 knockdown in
cells produced microvesicles. They incubated recipient cells with
vesicles shed from mDia2 knockdown cells and saw measurable
increases in proliferation and migration in in vitro assays.
These intriguing ﬁndings do not speciﬁcally implicate mDia2 or
other formins in cancer progression. However, they raise interesting
questions about such roles. Expression of dominant interfering mDia1
(truncated mDia1 FH2 domain), the same variant known to induce
blebbing, inhibits both mDia2 and mDia1 signaling to SRF [41].
Moreover, expression of the interfering mDia1 signiﬁcantly enhances
the tumor-forming capacity of Ras-transformed mouse embryo
ﬁbroblasts [42]. Whether the boost in tumor-forming ability is due
to increasedmicrovesicle production (perhaps secondary to enhanced
non-apoptotic membrane blebbing), or is due to diminished signaling
to the apoptotic machinery through SRF signaling to Egr1 [43], or to
other effects is unknown. Clearly, the role of mDia2 in such signaling
systems needs to be addressed in more detail.
5. Formins in immunity
Cytoskeletal remodeling is required to generate an effective
immune response. While formins are critical for cellular migration
and invasion (discussed in the previous section), they also mediate
polarity, adhesion, and activation of immune cells. Because of their
critical roles in T cells, neutrophils, and other hematopoietic cells,
formins may contribute to disease when their activity is disrupted in
immune cells.
5.1. T cell responses
Recent work by our group, and independently conﬁrmed by
others, discovered a central role for the formin mDia1 for in vivo
dynamic cytoskeletal remodeling driving T cell responses [28,44].
Focusing upon mice with targeted deletion of the gene encoding
mDia1, these studies collectively revealed the involvement of mDia1
in T cell development, proliferation and emigration into peripheral
lymphoid organs, including spleen and lymph node. These data are
consistent with considerable genetic evidence that Rho GTPases (e.g.,
RhoA), their regulatory exchange factors (e.g., Vav), and their
effectors (e.g., WASp) participate in normal T cell function. For
example, while both Vav−/− and WASp−/− animals are defective in
dynamic remodeling of actin following T cell receptor (TCR) ligation
[45,46], it is possible that the RhoGEF activity of Vav (speciﬁcally
toward RhoA) directly affects cytoskeletal remodeling upon TCR
stimulation. Indeed the small GTPase RhoA regulates integrin-
mediated T cell adhesion and migration [47,48]; while mDia1 is a
known RhoA effector, it is plausible that the defects in adhesion and
chemotactic migration may be due to disruption of RhoA-mediated
mDia1 activation and dysregulation of formin-mediated actin dy-
namics. Indeed, constitutively activated mDia1 (lacking the GTPase
binding and a portion of the Dia-inhibitory domain) dramatically
enhanced actin accumulation in Jurkat T cells in vitrowhile decreasing
chemotactic migration upon TCR engagement [49]; these results
suggest that arresting the dynamic actin and microtubule
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function, consistent with our results utilizing T cells derived from the
Drf1 knockout mouse. However, a recent study suggested that upon
depletion of mDia1, actin dynamics at the immune synapse were not
affected upon TCR stimulation [52]. mDia1 depletion was incomplete
in those studies (90% depletion as estimated by Chhabra and Higgs
[53]), and, along with the modest effects observed in F-actin
accumulation and cellular adhesion/migration, these results suggest
that a lower level of mDia1 protein is sufﬁcient to mediate actin
dynamics in stimulated T cells.
5.2. Neutrophil responses
Following the discovery of a role for mDia1 in regulating actin
dynamics critical for T cell migration, two recent studies also
demonstrated a role for mDia1 in neutrophil migration and activation
[54,55]. Using neutrophils isolated from mDia1 [56], WASp [46] or
mDia1/WASp double knockouts, these studies revealed an association
between mDia1 and WASp that was important for mediating
neutrophil polarization and chemotactic responses toward the
chemokine MIP-2 or the fMLP formyl peptide. These studies further
demonstrated that both Src family kinases and LARG/RhoA/ROCK
signaling contributed to the mDia1-mediated signaling axis promot-
ing neutrophil chemotaxis.
5.3. Other hematopoietic cells
The assembly of F-actin ﬁlaments into a contractile actin ring
(CAR) was previously shown to be fundamental to enucleation
[57,58], a process fundamental to erythyrocyte maturation in which
the pycnotic nucleus is extruded from the mature erythroid cell. Until
recently, the identity of actin-assembly factors mediating CAR
formation and enucleation remained elusive. However, Ji et al.
recently demonstrated a speciﬁc requirement for the formin mDia2,
through an association with Rac1 and Rac2, for CAR formation and
subsequent enucleation [59]. In those studies, Rac inhibition ablated
enucleation, while constitutively activated mDia2 was shown to
rescue the defect. As it has been postulated that enucleation is a
specialized form of cytokinesis, these results are consistent with
previous ﬁndings revealing a role for mDia2 in contractile ring
formation and in the completion of cytokinesis [13,60,61].
Finally, platelets exposed to thrombin are rapidly activated and
undergo dramatic RhoA-dependent reorganization of their actin
cytoskeleton [62,63]; yet until recently, it was unclear what Rho
effector proteins are required for propagating Rho-dependent
signaling in platelets. Two studies demonstrated a role for the
formins mDia1 and DAAM1 in promoting actin assembly/remodel-
ing and cell spreading in activated platelets in response to RhoA
signaling [64,65]. Collectively these ﬁndings, and those obtained in
the experiments on hematopoietic cells described above, suggest an
essential role for formin-mediated actin assembly in maintaining
proper homeostasis during immune function. Additional in vivo
analysis of mice deﬁcient in formin protein expression and valida-
tion in human samples will be an important avenue for future
studies.
6. Mouse models linking formins with disease
Multiple formin family members have been genetically manipu-
lated in mice to determine their in vivo functions. These studies have
revealed important roles for formins in development, immunity, and
disease. In some instances, the subtle phenotypes suggest that there is
functional redundancy between formins. Based on the current mouse
models, several diseases have been associated with impaired formin
function.6.1. Models of Fmn gene function
Leder and colleagues identiﬁed the initial Limb Deformity (Ld) loci
genes as having key roles in development programs that guide limb
formation [66,67]. Different transcripts with potential truncations
were identiﬁed at those loci and hybridization experiments pointed to
their expression in limb buds. It was then hypothesized that defects in
their gene function affected limb formation [7]. Continued analysis of
the Ld locus showed that while the Formin (Fmn) gene was near the
Ld locus, the protein encoded by Fmn was not affected in the original
knockout mice. Instead, defects in the Gremlin gene, which has
important functions in limb formation, were shown to account for
defects in Ld mice [7].
Recently, Fmn1 or Formin 1 knockout mice were shown to have a
limb deformity phenotype by reduction of digit number to four [68].
Importantly, there were no effects on Gremlin expression or function
as a result of Fmn1 knockout. These data suggest that Formin 1
function is indeed required for normal limb development in certain
contexts. Nevertheless, a role for Formin 1 in human development or
disease remains to be described.
Fmn2 knockout mice identiﬁed a role for Fmn2 function in the
meiotic cell divisions of mouse oocytes [69]. Knockout mice had
reduced fertility as a result of defects in spindle positioning and
polyploidy in oocytes. Since defects in oocyte maturation often result
in birth defects and pregnancy loss in humans, it is interesting to
speculate that problems with formin activity or expression may
contribute to these errors [69]. However, neither Fmn2 nor any other
formin family member has been speciﬁcally implicated in human
fertility defects to date.
6.2. Models of Drf gene function
Human myelodysplastic syndrome (MDS) is a hematopoietic
disorder due to defects in the control or differentiation of hematopoietic
stem or progenitor cells [70]. Clinically, MDS patients present with
various cytopenias, hypercellular marrow, dysplastic erythrocytes, and
an increased risk to develop AML [71]. One subset of MDS is 5q-
syndrome, which involves deletion of all or part of chromosome 5.
Interestingly, DIAPH1, which encodes mDia1, is located at or near
commonly deleted sites in 5q- patients. In fact, gene expression analysis
of patients with 5q-MDS shows decreasedDIAPH1 expression [43]. This
led to the hypothesis that mDia1 may have suppressor functions in the
maintenance of hematopoietic stemorprogenitor cell proliferation. This
idea was recently supported through genetic deletion of the Drf1 gene
in mice. Knockout mice developed an age-dependent myeloprolifera-
tive disorder, including splenomegaly, hypercellular bonemarrow, and
expansion of the myeloid and erythroid compartments in the spleen
and bone marrow [5]. The speciﬁc mechanism by which loss of mDia1
contributes to this phenotype remains to be determined, but it is
suggested that inappropriate signaling through the transcription factor
SRF plays a critical role [7,43,72].
Moreover, additional loss of RhoB enhanced themyeloproliferative
phenotype observed in mDia1 knockout mice alone. Compared to
mDia1 knockout mice, mice lacking both RhoB and mDia1 developed
a more severe myelodysplasia [73]. This is intriguing, given that RhoB
has been proposed to have tumor suppressor activity [74], and low
expression often correlates with late stage malignancy [75,76]. It will
be important to examine the role of formins and RhoB in the context
of stem or progenitor cell function, since myelodysplasia is considered
a disease of the stem cell compartment.
7. Alterations in formin expression or function associated with
disease
Aberrant formin function and expression have been directly
implicated in maladies as diverse as deafness [77], fertility defects
Table 1
Formin chromosome locations and human disease association.
Formin subfamily Name Gene ID Chromosome Disease relevancy
Dia—Diaphanous mDia1/DIAPH1 1729 5q31 5q- Myelodysplastic syndrome [5,43],
DFNA1 non-syndromic deafness [77]
mDia2/DIAPH3 1730 13q21.2 Chromosome deletion in metastatic prostate cancer [29]
mDia3/DIAPH2 81624 Xq21.33 Premature ovarian failure [78]
FRL—Formin-Related gene in
Leukocytes
FMNL1 752 17q21 Increased expression in lymphoid malignancies and
peripheral blood leukocytes from CLL patients [80]
FMNL2 114793 2q23.3 Increased expression in colorectal cancer [79]
FMNL3 91010 12q13.12
DAAM—Dishevelled-Associated
Activator of Morphogenesis
DAAM1 23002 14q23.1
DAAM2 23500 6p21.2
Delphilin GRID2IP 392862 7p22.1
INF—Inverted Formin FHDC1 85462 4q31.3
INF2 64423 14q32.33
FHOD—Formin Homology-
Domain-containing protein
FHOD1/FHOS 29109 16q22
FHOD3/FHOS2 80206 18q12
FMN—Formin FMN1 342184 15q13.3
FMN2 56776 1q43
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strating a causal role for formins in the formation of these diseases
have not been rigorously tested. Nevertheless, these studies point to
the importance of controlling formin activity for proper cell function.
7.1. DFNA1—autosomal dominant non-syndromic deafness
A progressive deafness disorder was discovered among a kindred
in Costa Rica that had descended from the Conquistadore invasions.
This disorder was named DFNA1 and was subsequently mapped to the
DIAPH1 gene [77]. The mutation in DIAPH1 is a four base pair (TTAA)
insertion that generates a frameshift mutation in the coding sequence
that is predicted to generate an inappropriate stop codon, truncating
32 amino acids (Fig. 3). However, the contribution of this mutation to
formin function has never been tested. Given the location of the
truncation, it is possible that the mutation may induce a gain-of-
function, by disrupting the autoinhibitory mechanism of mDia1.
7.2. Premature ovarian failure (POF)
Previous work has shown that a critical region on the X
chromosome is interrupted by a breakpoint associated with a familialFig. 3.Mutation in DIAPH1 leads to an autosomal dominant non-syndromic deafness disorde
the GTPase binding domain of autoregulated formins (e.g. mDia1) to sterically interfere with
autoregulation promotes formin-homology-2-domain-mediated actin polymerization. The D
acid sequence alignment of human mDia1, murine mDia1-3, and Drosophila diaphanou
autoregulation given the proximity of the truncation to the DAD domain. However, the trunca
may result in defective protein function not related to autoregulation.case of POF [78]. Mapping of the gene responsible for the ovarian
defect revealed that DIAPH2 (mDia3) may be the gene responsible
due to a breakpoint in the last intron. These ﬁndings suggest a possible
role for mDia3 in ovarian development. The cellular consequences of
the breakpoint for mDia3 function are unknown. However, a role for
formins in ovarian development is consistent with the spermato-
genesis and oogenesis defects observed in mutant versions of the
Drosophila dia gene [1].
7.3. Expression data associated with disease
Formin-like 2 (FMNL2) expression was shown to be elevated in
colorectal metastatic cancer cell lines compared to normal colorectal
cancer cell lines [79]. In addition, FMNL2 expression was higher in
primary colorectal cancer and lymph node metastases, with the
highest expression in the metastatic-derived cell lines. However, a
correlation between FMNL2 expression and clinical diagnosis was not
performed. Also unknown is whether increased FMNL2 expression
contributes to colorectal cancer formation, or if it is simply a
passenger effect due to other required genetic abnormalities.
The human leukocyte formin (FMNL1) is highly expressed in the
thymus, spleen, and peripheral blood leukocytes. It was reportedr. (A) Schematic diagram of the DIAPH1 encoded mDia1 protein. GTP-bound Rho binds
Dia inhibitory domain interaction with the Dia autoregulatory domain (DAD). Release of
FNA1 insertion is located at the C-terminal end of the DAD domain. (B) ClustalW amino
s. The DFNA1 insertion generates a truncated version of mDia1 that may disrupt
tion is on the C-terminal end of the most conserved DAD region, so the DFNA1 insertion
232 A.D. DeWard et al. / Biochimica et Biophysica Acta 1803 (2010) 226–233that high expression of FMNL1 is present in several lymphoid
cancer cell lines [80]. However, whether FMNL1 expression
correlates with lymphoid cancers from patient samples has not
been tested.
Experiments that implicate mDia2 in the negative regulation of
non-apoptotic blebbing and microvesicle formation suggest that
mDia2 (and perhaps other formins) exerts control over amoeboid
cell migration and/or other aspects of cancer progression [28,29].
For instance, genomic analysis of prostate cancer samples,
comparing primary tumors to metastases, suggests that deletions
at the DIAPH3 locus are signiﬁcantly more common in metastatic
disease [29]. DIAPH3 is located in a region of the q arm of
chromosome 13 (13q21.2), and while this region has been long
thought to harbor tumor suppressor genes [81], no tumor
suppressor genes have been speciﬁcally identiﬁed there. Further
work will clarify the extent to which mDia2 is functioning in that
role, but the ﬁndings to date indicate that such hypotheses are
worthy of careful examination.
8. Concluding remarks
Formins govern both actin and microtubule cytoskeletal dynam-
ics and play important roles in cell division, cell migration,
immunity, and development. While much of the knowledge about
formin function has been established using model organisms and in
vitro systems, there have been relatively few studies that directly
link formins with disease pathogenesis. The generation of new
mouse models and a more extensive characterization of the current
models will be useful to provide insights regarding the function of
formin family members in vivo. Future studies should address
speciﬁc hypotheses related to aberrant formin expression and
activity in disease. Are there disease-causing mutations in formins
that affect their activity? How does increased or decreased formin
expression facilitate disease, if at all? At this point, there are many
more questions than answers regarding the role of formins in
disease. Given the numerous cellular functions mediated by formins,
determining answers to these questions should prove to be a
rewarding endeavor.
References
[1] D.H. Castrillon, S.A. Wasserman, Diaphanous is required for cytokinesis in
Drosophila and shares domains of similarity with the products of the limb
deformity gene, Development 120 (1994) 3367–3377.
[2] F. Bartolini, G.G. Gundersen, Formins and microtubules, Biochim. Biophys. Acta
(2009), doi:10.1016/j.bbamcr.2009.07.006.
[3] F. Bartolini, J.B. Moseley, J. Schmoranzer, L. Cassimeris, B.L. Goode, G.G. Gundersen,
The formin mDia2 stabilizes microtubules independently of its actin nucleation
activity, J. Cell Biol. 181 (2008) 523–536.
[4] Y. Wen, C.H. Eng, J. Schmoranzer, N. Cabrera-Poch, E.J. Morris, M. Chen, B.J. Wallar,
A.S. Alberts, G.G. Gundersen, EB1 and APC bind to mDia to stabilize microtubules
downstream of Rho and promote cell migration, Nat. Cell Biol. 6 (2004) 820–830.
[5] J. Peng, S.M. Kitchen, R.A. West, R. Sigler, K.M. Eisenmann, A.S. Alberts,
Myeloproliferative defects following targeting of the Drf1 gene encoding the
mammalian diaphanous related forminmDia1, Cancer Res. 67 (2007) 7565–7571.
[6] D.A. Moulding, M.P. Blundell, D.G. Spiller, M.R. White, G.O. Cory, Y. Calle, H.
Kempski, J. Sinclair, P.J. Ancliff, C. Kinnon, G.E. Jones, A.J. Thrasher, Unregulated
actin polymerization by WASp causes defects of mitosis and cytokinesis in X-
linked neutropenia, J. Exp. Med. 204 (2007) 2213–2224.
[7] R. Liu, E.V. Linardopoulou, G.E. Osborn, S.M. Parkhurst, Formins in development:
orchestrating body plan origami, Biochim. Biophys. Acta (2008), doi:10.1016/j.
bbamcr.2008.09.016.
[8] A. Yonetani, R.J. Lustig, J.B. Moseley, T. Takeda, B.L. Goode, F. Chang, Regulation and
targeting of the ﬁssion yeast formin cdc12p in cytokinesis, Mol. Biol. Cell 19
(2008) 2208–2219.
[9] A.F. Severson, D.L. Baillie, B. Bowerman, A formin homology protein and a proﬁlin
are required for cytokinesis and Arp2/3-independent assembly of cortical
microﬁlaments in C. elegans, Curr. Biol. 12 (2002) 2066–2075.
[10] N.J. Ganem, Z. Storchova, D. Pellman, Tetraploidy, aneuploidy and cancer, Curr.
Opin. Genet. Dev. 17 (2007) 157–162.
[11] J.C. Canman, L.A. Cameron, P.S. Maddox, A. Straight, J.S. Tirnauer, T.J. Mitchison, G.
Fang, T.M. Kapoor, E.D. Salmon, Determining the position of the cell division
plane, Nature 424 (2003) 1074–1078.[12] T. Kato, N. Watanabe, Y. Morishima, A. Fujita, T. Ishizaki, S. Narumiya, Localization
of a mammalian homolog of diaphanous, mDia1, to the mitotic spindle in HeLa
cells, J. Cell. Sci. 114 (2001) 775–784.
[13] T. Tominaga, E. Sahai, P. Chardin, F. McCormick, S.A. Courtneidge, A.S. Alberts,
Diaphanous-related formins bridge Rho GTPase and Src tyrosine kinase signaling,
Mol. Cell 5 (2000) 13–25.
[14] M. Fernandez-Borja, L. Janssen, D. Verwoerd, P. Hordijk, J. Neefjes, RhoB regulates
endosome transport by promoting actin assembly on endosomal membranes
through Dia1, J. Cell. Sci. 118 (2005) 2661–2670.
[15] B.J. Wallar, A.D. DeWard, J.H. Resau, A.S. Alberts, RhoB and the mammalian
Diaphanous-related formin mDia2 in endosome trafﬁcking, Exp. Cell Res. 313
(2007) 560–571.
[16] S. Gasman, Y. Kalaidzidis, M. Zerial, RhoD regulates endosome dynamics through
Diaphanous-related formin and Src tyrosine kinase, Nat. Cell Biol. 5 (2003)
195–204.
[17] J. Magdalena, T.H. Millard, L.M. Machesky, Microtubule involvement in NIH
3T3 Golgi and MTOC polarity establishment, J. Cell. Sci. 116 (2003) 743–756.
[18] A.F. Palazzo, T.A. Cook, A.S. Alberts, G.G. Gundersen, mDia mediates Rho-
regulated formation and orientation of stable microtubules, Nat. Cell Biol. 3
(2001) 723–729.
[19] N. Yamana, Y. Arakawa, T. Nishino, K. Kurokawa, M. Tanji, R.E. Itoh, J. Monypenny,
T. Ishizaki, H. Bito, K. Nozaki, N. Hashimoto, M. Matsuda, S. Narumiya, The Rho-
mDia1 pathway regulates cell polarity and focal adhesion turnover in migrating
cells through mobilizing Apc and c-Src, Mol. Cell Biol. 26 (2006) 6844–6858.
[20] K. Zaoui, S. Honore, D. Isnardon, D. Braguer, A. Badache, Memo-RhoA-mDia1
signaling controls microtubules, the actin network, and adhesion site formation in
migrating cells, J. Cell Biol. 183 (2008) 401–408.
[21] T. Ishizaki, Y. Morishima, M. Okamoto, T. Furuyashiki, T. Kato, S. Narumiya,
Coordination of microtubules and the actin cytoskeleton by the Rho effector
mDia1, Nat. Cell Biol. 3 (2001) 8–14.
[22] S. Narumiya, M. Tanji, T. Ishizaki, Rho signaling, ROCK and mDia1, in
transformation, metastasis and invasion, Cancer Metastasis Rev. 28 (2009) 65–76.
[23] B. Wehrle-Haller, B.A. Imhof, Actin, microtubules and focal adhesion dynamics
during cell migration, Int. J. Biochem. Cell Biol. 35 (2003) 39–50.
[24] C. Sarmiento, W. Wang, A. Dovas, H. Yamaguchi, M. Sidani, M. El-Sibai, V.
Desmarais, H.A. Holman, S. Kitchen, J.M. Backer, A. Alberts, J. Condeelis, WASP
family members and formin proteins coordinate regulation of cell protrusions in
carcinoma cells, J. Cell Biol. 180 (2008) 1245–1260.
[25] D.T. Brandt, S. Marion, G. Grifﬁths, T. Watanabe, K. Kaibuchi, R. Grosse, Dia1 and
IQGAP1 interact in cell migration and phagocytic cup formation, J. Cell Biol. 178
(2007) 193–200.
[26] B.I. Hudson, A.Z. Kalea, M. Del Mar Arriero, E. Harja, E. Boulanger, V. D'Agati, A.M.
Schmidt, Interaction of the RAGE cytoplasmic domain with diaphanous-1 is
required for ligand-stimulated cellular migration through activation of Rac1 and
Cdc42, J. Biol. Chem. 283 (2008) 34457–34468.
[27] S.L. Lai, T.H. Chan, M.J. Lin, W.P. Huang, S.W. Lou, S.J. Lee, Diaphanous-related
formin 2 and proﬁlin I are required for gastrulation cell movements, PLoS One 3
(2008) e3439.
[28] K.M. Eisenmann, E.S. Harris, S.M. Kitchen, H.A. Holman, H.N. Higgs, A.S. Alberts,
Dia-interacting protein modulates formin-mediated actin assembly at the cell
cortex, Curr. Biol. 17 (2007) 579–591.
[29] D. Di Vizio, J. Kim, M.H. Hager, M. Morello, W. Yang, C.J. Lafargue, L.D. True, M.A.
Rubin, R.M. Adam, R. Beroukhim, F. Demichelis, M.R. Freeman, Oncosome
formation in prostate cancer: association with a region of frequent chromosomal
deletion in metastatic disease, Cancer Res. 69 (2009) 5601–5609.
[30] F. Lizarraga, R. Poincloux, M. Romao, G. Montagnac, G. Le Dez, I. Bonne, G.
Rigaill, G. Raposo, P. Chavrier, Diaphanous-related formins are required for
invadopodia formation and invasion of breast tumor cells, Cancer Res. 69
(2009) 2792–2800.
[31] S.L. Gupton, K. Eisenmann, A.S. Alberts, C.M. Waterman-Storer, mDia2 regulates
actin and focal adhesion dynamics and organization in the lamella for efﬁcient
epithelial cell migration, J. Cell. Sci. 120 (2007) 3475–3487.
[32] S. Koka, C.L. Neudauer, X. Li, R.E. Lewis, J.B. McCarthy, J.J. Westendorf, The formin-
homology-domain-containing protein FHOD1 enhances cell migration, J. Cell. Sci.
116 (2003) 1745–1755.
[33] M. Dettenhofer, F. Zhou, P. Leder, Formin 1-isoform IV deﬁcient cells exhibit
defects in cell spreading and focal adhesion formation, PLoS One 3 (2008)
e2497.
[34] A. Wynshaw-Boris, G. Ryan, C.X. Deng, D.C. Chan, L. Jackson-Grusby, D. Larson, J.H.
Dunmore, P. Leder, The role of a single formin isoform in the limb and renal
phenotypes of limb deformity, Mol. Med. 3 (1997) 372–384.
[35] A. Schirenbeck, T. Bretschneider, R. Arasada, M. Schleicher, J. Faix, The
Diaphanous-related formin dDia2 is required for the formation and maintenance
of ﬁlopodia, Nat. Cell Biol. 7 (2005) 619–625.
[36] S. Yayoshi-Yamamoto, I. Taniuchi, T. Watanabe, FRL, a novel formin-related
protein, binds to Rac and regulates cell motility and survival of macrophages, Mol.
Cell Biol. 20 (2000) 6872–6881.
[37] H.N. Higgs, Formin proteins: a domain-based approach, Trends Biochem. Sci. 30
(2005) 342–353.
[38] K. Al-Nedawi, B. Meehan, J. Micallef, V. Lhotak, L. May, A. Guha, J. Rak, Intercellular
transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour
cells, Nat. Cell Biol. 10 (2008) 619–624.
[39] K. Al-Nedawi, B. Meehan, J. Rak, Microvesicles: messengers and mediators of
tumor progression, Cell Cycle 8 (2009) 2014–2018.
[40] B.J. Wallar, A.S. Alberts, The formins: active scaffolds that remodel the
cytoskeleton, Trends Cell Biol. 13 (2003) 435–446.
233A.D. DeWard et al. / Biochimica et Biophysica Acta 1803 (2010) 226–233[41] J.W. Copeland, R. Treisman, The diaphanous-related formin mDia1 controls serum
response factor activity through its effects on actin polymerization, Mol. Biol. Cell
13 (2002) 4088–4099.
[42] U. Kamasani, J.B. Duhadaway, A.S. Alberts, G.C. Prendergast, mDia function is
critical for the cell suicide program triggered by farnesyl transferase inhibition,
Cancer Biol. Ther. 6 (2007) 1422–1427.
[43] K.M. Eisenmann, K.J. Dykema, S.F. Matheson, N.F. Kent, A.D. DeWard, R.A. West, R.
Tibes, K.A. Furge, A.S. Alberts, 5q- Myelodysplastic syndromes: chromosome 5q
genes direct a tumor-suppression network sensing actin dynamics, Oncogene 28
(2009) 3429–3441.
[44] D. Sakata, H. Taniguchi, S. Yasuda, A. Adachi-Morishima, Y. Hamazaki, R.
Nakayama, T. Miki, N. Minato, S. Narumiya, Impaired T lymphocyte trafﬁcking
in mice deﬁcient in an actin-nucleating protein, mDia1, J. Exp. Med. 204 (2007)
2031–2038.
[45] K.D. Fischer, Y.Y. Kong, H. Nishina, K. Tedford, L.E. Marengere, I. Kozieradzki, T.
Sasaki, M. Starr, G. Chan, S. Gardener, M.P. Nghiem, D. Bouchard, M. Barbacid, A.
Bernstein, J.M. Penninger, Vav is a regulator of cytoskeletal reorganization
mediated by the T-cell receptor, Curr. Biol. 8 (1998) 554–562.
[46] J. Zhang, A. Shehabeldin, L.A. da Cruz, J. Butler, A.K. Somani, M. McGavin, I.
Kozieradzki, A.O. dos Santos, A. Nagy, S. Grinstein, J.M. Penninger, K.A.
Siminovitch, Antigen receptor-induced activation and cytoskeletal rearrangement
are impaired in Wiskott–Aldrich syndrome protein-deﬁcient lymphocytes, J. Exp.
Med. 190 (1999) 1329–1342.
[47] D.A. Cantrell, GTPases and T cell activation, Immunol. Rev. 192 (2003) 122–130.
[48] R. Pasvolsky, V. Grabovsky, C. Giagulli, Z. Shulman, R. Shamri, S.W. Feigelson, C.
Laudanna, R. Alon, RhoA is involved in LFA-1 extension triggered by CXCL12 but
not in a novel outside-in LFA-1 activation facilitated by CXCL9, J. Immunol. 180
(2008) 2815–2823.
[49] M. Vicente-Manzanares, M. Rey, M. Perez-Martinez, M. Yanez-Mo, D. Sancho, J.
R. Cabrero, O. Barreiro, H. de la Fuente, K. Itoh, F. Sanchez-Madrid, The RhoA
effector mDia is induced during T cell activation and regulates actin
polymerization and cell migration in T lymphocytes, J. Immunol. 171 (2003)
1023–1034.
[50] B.J. Wallar, B.N. Stropich, J.A. Schoenherr, H.A. Holman, S.M. Kitchen, A.S. Alberts,
The basic region of the diaphanous-autoregulatory domain (DAD) is required for
autoregulatory interactions with the diaphanous-related formin inhibitory
domain, J. Biol. Chem. 281 (2006) 4300–4307.
[51] N. Watanabe, T. Kato, A. Fujita, T. Ishizaki, S. Narumiya, Cooperation between
mDia1 and ROCK in Rho-induced actin reorganization, Nat. Cell Biol. 1 (1999)
136–143.
[52] T.S. Gomez, K. Kumar, R.B. Medeiros, Y. Shimizu, P.J. Leibson, D.D. Billadeau,
Formins regulate the actin-related protein 2/3 complex-independent polariza-
tion of the centrosome to the immunological synapse, Immunity 26 (2007)
177–190.
[53] E.S. Chhabra, H.N. Higgs, The many faces of actin: matching assembly factors with
cellular structures, Nat. Cell Biol. 9 (2007) 1110–1121.
[54] Y. Shi, B. Dong, H. Miliotis, J. Liu, A.S. Alberts, J. Zhang, K.A. Siminovitch, Src kinase
Hck association with the WASp and mDia1 cytoskeletal regulators promotes
chemoattractant-induced Hck membrane targeting and activation in neutrophils,
Biochem. Cell. Biol. 87 (2009) 207–216.
[55] Y. Shi, J. Zhang, M. Mullin, B. Dong, A.S. Alberts, K.A. Siminovitch, The mDial
formin is required for neutrophil polarization, migration, and activation of the
LARG/RhoA/ROCK signaling axis during chemotaxis, J. Immunol. 182 (2009)
3837–3845.
[56] J. Peng, B.J. Wallar, A. Flanders, P.J. Swiatek, A.S. Alberts, Disruption of the
Diaphanous-related formin Drf1 gene encoding mDia1 reveals a role for Drf3 as an
effector for Cdc42, Curr. Biol. 13 (2003) 534–545.
[57] J.A. Chasis, M. Prenant, A. Leung, N. Mohandas, Membrane assembly and
remodeling during reticulocyte maturation, Blood 74 (1989) 1112–1120.
[58] S.T. Koury, M.J. Koury, M.C. Bondurant, Cytoskeletal distribution and function
during the maturation and enucleation of mammalian erythroblasts, J. Cell Biol.
109 (1989) 3005–3013.
[59] P. Ji, S.R. Jayapal, H.F. Lodish, Enucleation of cultured mouse fetal erythroblasts
requires Rac GTPases and mDia2, Nat. Cell Biol. 10 (2008) 314–321.
[60] A.D. Deward, A.S. Alberts, Ubiquitin-mediated degradation of the formin mDia2
upon completion of cell division, J. Biol. Chem. 284 (2009) 20061–20069.[61] S. Watanabe, Y. Ando, S. Yasuda, H. Hosoya, N. Watanabe, T. Ishizaki, S. Narumiya,
mDia2 induces the actin scaffold for the contractile ring and stabilizes its position
during cytokinesis in NIH 3T3 cells, Mol. Biol. Cell 19 (2008) 2328–2338.
[62] L. Leng, H. Kashiwagi, X.D. Ren, S.J. Shattil, RhoA and the function of platelet
integrin alphaIIbbeta3, Blood 91 (1998) 4206–4215.
[63] S.M. Schoenwaelder, S.C. Hughan, K. Boniface, S. Fernando, M. Holdsworth, P.E.
Thompson, H.H. Salem, S.P. Jackson, RhoA sustains integrin alpha IIbbeta 3
adhesion contacts under high shear, J. Biol. Chem. 277 (2002) 14738–14746.
[64] G. Gao, L. Chen, B. Dong, H. Gu, H. Dong, Y. Pan, Y. Gao, X. Chen, RhoA effector
mDia1 is required for PI 3-kinase-dependent actin remodeling and spreading by
thrombin in platelets, Biochem. Biophys. Res. Commun. 385 (2009) 439–444.
[65] T. Higashi, T. Ikeda, R. Shirakawa, H. Kondo, M. Kawato, M. Horiguchi, T. Okuda, K.
Okawa, S. Fukai, O. Nureki, T. Kita, H. Horiuchi, Biochemical characterization of the
Rho GTPase-regulated actin assembly by diaphanous-related formins, mDia1 and
Daam1, in platelets, J. Biol. Chem. 283 (2008) 8746–8755.
[66] R.L. Mass, R. Zeller, R.P. Woychik, T.F. Vogt, P. Leder, Disruption of formin-
encoding transcripts in two mutant limb deformity alleles, Nature 346 (1990)
853–855.
[67] R.P. Woychik, R.L. Maas, R. Zeller, T.F. Vogt, P. Leder, ‘Formins’: proteins deduced
from the alternative transcripts of the limb deformity gene, Nature 346 (1990)
850–853.
[68] F. Zhou, P. Leder, A. Zuniga, M. Dettenhofer, Formin1 disruption confers
oligodactylism and alters Bmp signaling, Hum. Mol. Genet. 18 (2009) 2472–2482.
[69] B. Leader, H. Lim, M.J. Carabatsos, A. Harrington, J. Ecsedy, D. Pellman, R. Maas, P.
Leder, Formin-2, polyploidy, hypofertility and positioning of the meiotic spindle
in mouse oocytes, Nat. Cell Biol. 4 (2002) 921–928.
[70] S.D. Nimer, MDS: a stem cell disorder—but what exactly is wrong with the
primitive hematopoietic cells in this disease? Hematol. Am. Soc. Hematol. Educ.
Program 2008 (2008) 43–51.
[71] L. Malcovati, S.D. Nimer, Myelodysplastic syndromes: diagnosis and staging,
Cancer Control 15 Suppl. (2008) 4–13.
[72] K.G. Young, J.W. Copeland, Formins in cell signaling, Biochim. Biophys. Acta
(2008), doi:10.1016/j.bbamer.2008.09.17.
[73] A.D. DeWard, K. Leali, R.A. West, G.C. Prendergast, A.S. Alberts, Loss of RhoB
expression enhances the myelodysplastic phenotype of mammalian diaphanous-
related formin mDia1 knockout mice, PLoS One 4 (2009) e7102.
[74] G.C. Prendergast, Actin' up: RhoB in cancer and apoptosis, Nat. Rev., Cancer 1
(2001) 162–168.
[75] N. Sato, T. Fukui, T. Taniguchi, T. Yokoyama, M. Kondo, T. Nagasaka, Y. Goto, W.
Gao, Y. Ueda, K. Yokoi, J.D. Minna, H. Osada, Y. Kondo, Y. Sekido, RhoB is frequently
downregulated in non-small-cell lung cancer and resides in the 2p24 homozy-
gous deletion region of a lung cancer cell line, Int. J. Cancer 120 (2007) 543–551.
[76] B. Couderc, A. Pradines, A. Raﬁi, M. Golzio, A. Deviers, C. Allal, D. Berg, M. Penary, J.
Teissie, G. Favre, In vivo restoration of RhoB expression leads to ovarian tumor
regression, Cancer Gene Ther. 15 (2008) 456–464.
[77] E.D. Lynch, M.K. Lee, J.E. Morrow, P.L. Welcsh, P.E. Leon, M.C. King, Nonsyndromic
deafness DFNA1 associated with mutation of a human homolog of the Drosophila
gene diaphanous, Science 278 (1997) 1315–1318.
[78] S. Bione, C. Sala, C. Manzini, G. Arrigo, O. Zuffardi, S. Banﬁ, G. Borsani, P. Jonveaux,
C. Philippe, M. Zuccotti, A. Ballabio, D. Toniolo, A human homologue of the
Drosophila melanogaster diaphanous gene is disrupted in a patient with
premature ovarian failure: evidence for conserved function in oogenesis and
implications for human sterility, Am. J. Hum. Genet. 62 (1998) 533–541.
[79] X.L. Zhu, L. Liang, Y.Q. Ding, Overexpression of FMNL2 is closely related to
metastasis of colorectal cancer, Int. J. Colorectal Dis. 23 (2008) 1041–1047.
[80] P.M. Favaro, S. de Souza Medina, F. Traina, D.S. Basseres, F.F. Costa, S.T. Saad,
Human leukocyte formin: a novel protein expressed in lymphoid malignancies
and associated with Akt, Biochem. Biophys. Res. Commun. 311 (2003) 365–371.
[81] T. Kainu, S.H. Juo, R. Desper, A.A. Schaffer, E. Gillanders, E. Rozenblum, D.
Freas-Lutz, D.Weaver, D. Stephan, J. Bailey-Wilson, O.P. Kallioniemi,M. Tirkkonen,
K. Syrjakoski, T. Kuukasjarvi, P. Koivisto, R. Karhu, K. Holli, A. Arason, G.
Johannesdottir, J.T. Bergthorsson, H. Johannsdottir, V. Egilsson, R.B. Barkardottir,
O. Johannsson, K. Haraldsson, T. Sandberg, E. Holmberg, H. Gronberg, H. Olsson, A.
Borg, P. Vehmanen, H. Eerola, P. Heikkila, S. Pyrhonen, H. Nevanlinna, Somatic
deletions in hereditary breast cancers implicate 13q21 as a putative novel breast
cancer susceptibility locus, Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 9603–9608.
